loadpatents
name:-0.057698011398315
name:-0.024832010269165
name:-0.011157989501953
Bowers; Simeon Patent Filings

Bowers; Simeon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bowers; Simeon.The latest application filed is for "compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (pcsk9)".

Company Profile
11.25.47
  • Bowers; Simeon - Oakland CA
  • Bowers; Simeon - Cambridge MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds For The Modulation Of Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9)
App 20220267269 - Bowers; Simeon ;   et al.
2022-08-25
Compounds For The Modulation Of Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9)
App 20220193058 - Bowers; Simeon ;   et al.
2022-06-23
Inhibitors Of Jun N-terminal Kinase
App 20220081427 - SHAM; Hing L. ;   et al.
2022-03-17
Composition And Methods Of Use Of Tetrahydroisoquinoline Small Molecules To Bind And Modulate Pcsk9 Protein Activity
App 20210309613 - Barta; Thomas E. ;   et al.
2021-10-07
Composition And Methods Of Use Of Novel Phenylalanine Small Organic Compounds To Directly Modulate Pcsk9 Protein Activity
App 20210236481 - Barta; Thomas E. ;   et al.
2021-08-05
Tripeptide epoxy ketone protease inhibitors
Grant 11,078,233 - McMinn , et al. August 3, 2
2021-08-03
Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use
Grant 10,980,801 - Barta , et al. April 20, 2
2021-04-20
Compounds For Binding Proprotein Convertase Subtilisin/kexin Type 9
App 20210032214 - Pandey; Anjali ;   et al.
2021-02-04
Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity
Grant 10,865,185 - Barta , et al. December 15, 2
2020-12-15
Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity
Grant 10,821,106 - Barta , et al. November 3, 2
2020-11-03
Inhibitors Of Jun N-terminal Kinase
App 20200277285 - SHAM; Hing L. ;   et al.
2020-09-03
Phenylpiperazine Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) Modulators And Their Use
App 20200253958 - Kind Code
2020-08-13
Tripeptide Epoxy Ketone Protease Inhibitors
App 20200207809 - McMinn; Dustin ;   et al.
2020-07-02
Tripeptide epoxy ketone protease inhibitors
Grant 10,647,744 - McMinn , et al.
2020-05-12
Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use
Grant 10,568,882 - Barta , et al. Feb
2020-02-25
Inhibitors Of Jun N-terminal Kinase
App 20200039972 - SHAM; Hing L. ;   et al.
2020-02-06
Novel Antibody-drug Conjugates And Related Compounds, Compositions And Methods Of Use
App 20190209704 - JACKSON; David Y. ;   et al.
2019-07-11
Inhibitors Of Jun N-terminal Kinase
App 20190194176 - SHAM; Hing L. ;   et al.
2019-06-27
Compounds For Binding Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9)
App 20190119236 - Pandey; Anjali ;   et al.
2019-04-25
Peptide epoxyketone immunoproteasome inhibitors
Grant RE47,302 - McMinn , et al.
2019-03-19
Inhibitors Of Jun N-terminal Kinase
App 20180319780 - SHAM; Hing L. ;   et al.
2018-11-08
Composition And Methods Of Use Of Novel Phenylalanine Small Organic Compounds To Directly Modulate Pcsk9 Protein Activity
App 20180250291 - Barta; Thomas E. ;   et al.
2018-09-06
Composition And Methods Of Use Of Novel Phenylalanine Small Organic Compounds To Directly Modulate Pcsk9 Protein Activity
App 20180237381 - Barta; Thomas E. ;   et al.
2018-08-23
Inhibitors Of Jun N-terminal Kinase
App 20180037577 - SHAM; Hing L. ;   et al.
2018-02-08
Substituted cinnolines as inhibitors of LRRK2 kinase activity
Grant 9,884,828 - Aubele , et al. February 6, 2
2018-02-06
Inhibitors of Jun N-terminal kinase
Grant 9,796,706 - Sham , et al. October 24, 2
2017-10-24
Inhibitors Of Jun N-terminal Kinase
App 20170107209 - SHAM; Hing L. ;   et al.
2017-04-20
Tripeptide Epoxy Ketone Protease Inhibitors
App 20160368946 - McMinn; Dustin ;   et al.
2016-12-22
Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof
Grant 9,493,485 - Xu , et al. November 15, 2
2016-11-15
Spirocyclic Dihydro-thiazine And Dihydro-oxazine Bace Inhibitors, And Compositions And Uses Thereof
App 20160272654 - XU; Ying-Zi ;   et al.
2016-09-22
Tripeptide epoxy ketone protease inhibitors
Grant 9,434,761 - McMinn , et al. September 6, 2
2016-09-06
Spirocyclic Dihydro-thiazine And Dihydro-oxazine Bace Inhibitors, And Compositions And Uses Thereof
App 20150307518 - Xu; Ying-Zi ;   et al.
2015-10-29
Inhibitors Of Lrrk2 Kinase Activity
App 20150284337 - Aubele; Danielle L. ;   et al.
2015-10-08
Inhibitors Of Jun N-terminal Kinase
App 20150259330 - SHAM; Hing L. ;   et al.
2015-09-17
Inhibitors of Jun N-terminal kinase
Grant 9,073,891 - Sham , et al. July 7, 2
2015-07-07
Inhibitors Of Polo-like Kinase
App 20150126502 - GALEMMO; Robert A. ;   et al.
2015-05-07
Spirocyclic Digydro-thiazine And Dihydro-oxazine Bace Inhibitors, And Compositions And Uses Thereof
App 20150087825 - Xu; Ying-Zi ;   et al.
2015-03-26
Spirocyclic Digydro-thiazine And Dihydro-oxazine Bace Inhibitors, And Compositions And Uses Thereof
App 20150087826 - Xu; Ying-Zi ;   et al.
2015-03-26
Tripeptide Epoxy Ketone Protease Inhibitors
App 20140336106 - McMinn; Dustin ;   et al.
2014-11-13
Inhibitors Of Polo-like Kinase
App 20130331376 - Galemmo; Robert A. ;   et al.
2013-12-12
Inhibitors of polo-like kinase
Grant 8,541,418 - Galemmo , et al. September 24, 2
2013-09-24
Inhibitors Of Polo-like Kinase
App 20130231335 - Galemmo; Robert A. ;   et al.
2013-09-05
Inhibitors of Jun N-terminal kinase
Grant 8,450,363 - Sham , et al. May 28, 2
2013-05-28
Inhibitors of polo-like kinase
Grant 8,445,503 - Galemmo , et al. May 21, 2
2013-05-21
Inhibitors Of Jun N-terminal Kinase
App 20130072494 - SHAM; Hing L. ;   et al.
2013-03-21
N-sulfonamido polycyclic pyrazolyl compounds
Grant 8,283,358 - Konradi , et al. October 9, 2
2012-10-09
Inhibitors of Polo-Like Kinase
App 20120115848 - Galemmo, JR.; Robert A. ;   et al.
2012-05-10
Inhibitors Of Polo-like Kinase
App 20110212942 - Galemmo; Robert A. ;   et al.
2011-09-01
Inhibitors Of Polo-like Kinase
App 20110207716 - Galemmo; Robert A. ;   et al.
2011-08-25
Pyrazolopyrrolidines as inhibitors of gamma secretase
Grant 7,977,368 - Dressen , et al. July 12, 2
2011-07-12
Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase
App 20110003802 - Bowers; Simeon ;   et al.
2011-01-06
Inhibitors of Jun N-Terminal Kinase
App 20100331335 - Sham; Hing L. ;   et al.
2010-12-30
Substituted hydroxyethylamine aspartyl protease inhibitors
Grant 7,858,642 - John , et al. December 28, 2
2010-12-28
Bridged N-cyclic sulfonamido inhibitors of gamma secretase
Grant 7,754,712 - Bowers , et al. July 13, 2
2010-07-13
N-sulfonamido Polycyclic Pyrazolyl Compounds
App 20100081680 - Konradi; Andrei W. ;   et al.
2010-04-01
Substituted Hydroxyethylamine Aspartyl Protease Inhibitors
App 20090270367 - JOHN; Varghese ;   et al.
2009-10-29
Pyrazolopyrrolidines as Inhibitors of Gamma Secretase
App 20090099235 - Dressen; Darren ;   et al.
2009-04-16
Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase
App 20080090817 - Bowers; Simeon ;   et al.
2008-04-17
Bridged N-cyclic sulfonamido inhibitors of gamma secretase
Grant 7,345,056 - Bowers , et al. March 18, 2
2008-03-18
Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
App 20070149525 - Hom; Roy ;   et al.
2007-06-28
Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase
App 20070049612 - Bowers; Simeon ;   et al.
2007-03-01
Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors
App 20050239832 - John, Varghese ;   et al.
2005-10-27
Substituted hydroxyethylamine aspartyl protease inhibitors
App 20050239836 - John, Varghese ;   et al.
2005-10-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed